Figure 3.

Secondary efficacy outcome: probability of experiencing no seizures over the 24‐hour observation period after 10 minutes of double‐blind trial drug administration based on a Kaplan‐Meier analysis of time‐to‐next seizure in the modified intent‐to‐treat population. Patients who did not have another seizure before the end of the 24‐hour observation period, and who had not been administered the second dose of trial drug, were censored at the end of the observation period. Those administered the second dose of trial drug who did not have a seizure before the administration of the second dose were censored at the time of the second dose